ロード中...
MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer
Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer with poor prognosis due to lack of druggable targets such as hormone and growth factor receptors. Therefore, identification of targetable regulators such as miRNAs could provide new avenues for therapeutic applications...
保存先:
| 出版年: | Cancer Biol Ther |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6605987/ https://ncbi.nlm.nih.gov/pubmed/30922194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1595285 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|